Top Medical Stocks To Watch Right Now

BioXel Therapeutics has filed an S-1 form with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO). No pricing details weregiven in the filing, but the offering is valued up to $69.0 million. The company intends to list its shares on the Nasdaq under the symbol BTAI.

The underwriters for the offering are Barclays, UBS Investment Bank and BMO Capital Markets.

This is a clinical-stage biopharmaceutical company focused on drug development that utilizes novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology.

The firms drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and proprietary machine learning algorithms to identify new therapeutic indices.

Management believes that this differentiated approach has the potential to reduce the cost and time of drug development in diseases with substantial unmet medical need.

Top Medical Stocks To Watch Right Now: Plains Group Holdings, L.P.(PAGP)

Advisors’ Opinion:

  • [By Stephan Byrd]

    TheStreet upgraded shares of Plains GP (NYSE:PAGP) from a d+ rating to a c- rating in a research report released on Monday morning.

    Several other analysts have also recently issued reports on the company. Stifel Nicolaus cut Plains GP from a buy rating to a hold rating and set a $24.00 price objective on the stock. in a report on Wednesday. Jefferies Group cut Plains GP from a buy rating to a hold rating in a report on Wednesday, April 25th. Wolfe Research cut Plains GP from a market perform rating to an underperform rating in a report on Tuesday, April 24th. Deutsche Bank began coverage on Plains GP in a report on Thursday, April 19th. They set a buy rating and a $29.00 price objective on the stock. Finally, SunTrust Banks raised Plains GP from a hold rating to a buy rating and set a $27.00 price objective on the stock in a report on Monday, April 9th. Two equities research analysts have rated the stock with a sell rating, eight have given a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company. The company presently has an average rating of Hold and a consensus price target of $25.65.

  • [By Joseph Griffin]

    Here are some of the news articles that may have impacted Accern’s rankings:

    Get Plains GP alerts:

    Plains GP (PAGP) Posts Quarterly Earnings Results, Misses Expectations By $0.08 EPS (americanbankingnews.com) Plains GP (PAGP) Upgraded by TheStreet to C- (americanbankingnews.com) Plains GP (PAGP) Downgraded by Stifel Nicolaus (americanbankingnews.com) Plains GP Holdings (PAGP) Tops Q1 EPS by 5c, Beats on Revenues (streetinsider.com) Plains All American Pipeline, L.P. and Plains GP Holdings Report First-Quarter 2018 Results (finance.yahoo.com)

    Several research firms have commented on PAGP. TheStreet upgraded shares of Plains GP from a “d+” rating to a “c-” rating in a research report on Monday. Stifel Nicolaus cut shares of Plains GP from a “buy” rating to a “hold” rating and set a $24.00 target price for the company. in a research report on Wednesday. Jefferies Group cut shares of Plains GP from a “buy” rating to a “hold” rating in a research report on Wednesday, April 25th. Wolfe Research cut shares of Plains GP from a “market perform” rating to an “underperform” rating in a research report on Tuesday, April 24th. Finally, Deutsche Bank began coverage on shares of Plains GP in a research report on Thursday, April 19th. They issued a “buy” rating and a $29.00 target price for the company. Two research analysts have rated the stock with a sell rating, eight have issued a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $25.65.

  • [By Lisa Levin]

     

    Companies Reporting After The Bell
    Marriott International, Inc. (NASDAQ: MAR) is projected to post quarterly earnings at $1.22 per share on revenue of $5.72 billion.
    Electronic Arts Inc. (NASDAQ: EA) is estimated to post quarterly earnings at $1.04 per share on revenue of $5.68 billion.
    The Walt Disney Company (NYSE: DIS) is projected to post quarterly earnings at $1.68 per share on revenue of $14.05 billion.
    Papa John's International, Inc. (NASDAQ: PZZA) is expected to post quarterly earnings at $0.62 per share on revenue of $441.73 million.
    Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is projected to post quarterly earnings at $2.77 per share on revenue of $434.87 million.
    Sun Life Financial Inc. (NYSE: SLF) is estimated to post quarterly earnings at $0.89 per share on revenue of $6.38 billion.
    LATAM Airlines Group S.A. (NYSE: LTM) is expected to post quarterly earnings at $0.16 per share on revenue of $2.70 billion.
    Liberty Global plc (NASDAQ: LBTYA) is projected to post quarterly earnings at $0.02 per share on revenue of $4.05 billion.
    TripAdvisor, Inc. (NASDAQ: TRIP) is expected to post quarterly earnings at $0.16 per share on revenue of $362.11 million.
    The Wendy's Company (NASDAQ: WEN) is projected to post quarterly earnings at $0.1 per share on revenue of $379.98 million.
    A-Mark Precious Metals, Inc. (NASDAQ: AMRK) is expected to post quarterly earnings at $0.06 per share on revenue of $1.69 billion.
    Monster Beverage Corporation (NASDAQ: MNST) is estimated to post quarterly earnings at $0.4 per share on revenue of $849.38 million.
    Convergys Corporation (NYSE: CVG) is expected to post quarterly earnings at $0.4 per share on revenue of $670.10 million.
    ScanSource, Inc. (NASDAQ: SCSC) is projected to post quarterly earnings at $0.7 per share on revenue of $875.91 million.
    KAR Auction Services, Inc. (NYSE: KAR) is expected to post quarterly earnings at $0.76 per share on revenue of $923.13

Top Medical Stocks To Watch Right Now: Yum! Brands, Inc.(YUM)

Advisors’ Opinion:

  • [By ]

    For example, when Kentucky Fried Chicken changed its name to KFC (NYSE: YUM), it did so to get the word “fried” out of its advertising in an age of health-conscious customers. Cigarette maker Phillip Morris did the same when they rebranded to Altria (NYSE: MO) in 2003. The political pressures associated with “big tobacco” created a need for a less caustic moniker.

  • [By ]

    Among McDonald’s main rivals, identified by FactSet, are Starbucks Corp. (SBUX) , down almost 5.5%; Yum! Brands (YUM) , which owns KFC, Pizza Hut and Taco Bell, up 32%; and burger chain Sonic Corp. (SONC) , down about 2%. These are all year-over-year percentages.

  • [By ]

    These figures should be a relief for Niccol, who joined the company from Yum! Brands’ (YUM) Taco Bell in February. While he was largely welcomed by investors and received industry affirmation, some critics were skeptical of his franchising background, operational savvy and the disparity in ethos between Chipotle and Taco Bell.

Top Medical Stocks To Watch Right Now: Xilinx, Inc.(XLNX)

Advisors’ Opinion:

  • [By Shane Hupp]

    Daiwa Securities Group Inc. raised its holdings in shares of Xilinx (NASDAQ:XLNX) by 1.9% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 126,150 shares of the programmable devices maker’s stock after purchasing an additional 2,349 shares during the quarter. Daiwa Securities Group Inc.’s holdings in Xilinx were worth $9,113,000 as of its most recent SEC filing.

  • [By Ethan Ryder]

    Headlines about Xilinx (NASDAQ:XLNX) have trended somewhat positive this week, according to Accern. The research group identifies negative and positive media coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Xilinx earned a coverage optimism score of 0.18 on Accern’s scale. Accern also assigned media stories about the programmable devices maker an impact score of 47.7615347434404 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

  • [By ]

    Xilinx (XLNX) : “I think it’s time to start getting back into NVIDIA (NVDA) .”

    Celgene (CELG) : “I’d rather buy Amgen (AMGN) or Regeneron Pharmaceuticals (REGN) . I think Celgene overpaid for that acquisition a few years ago.”

  • [By ]

    Cramer was bearish on Xilinx (XLNX) , Celgene (CELG) , Exelixis (EXEL) , Moneygram (MGI) , Monster Beverage (MNST) , SunCoke Energy Partners (SXCP) and Mattel (MAT) .

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Friday was Xilinx, Inc. (NASDAQ: XLNX) which rose about 5% to $74.15. The stocks 52-week range is $54.99 to $75.14. Volume was 5.6 million compared to its average volume of 2 million.

  • [By ]

    Until it’s lifted, the ban stands to impact everyone from optical component/module suppliers such as Acacia Communications (ACIA)  and Oclaro to telecom/networking chip suppliers such as Cavium (CAVM)  and Xilinx (XLNX) to mobile chip suppliers such as Qualcomm (QCOM)  and Skyworks (SWKS) . Some of the damage will, of course, be offset by share losses ZTE is likely to see on account of the ban. This could particularly hold for mobile suppliers, given that the ban could prevent ZTE from shipping phones running Alphabet/Google’s (GOOGL) version of Android.

Top Medical Stocks To Watch Right Now: Signet Jewelers Limited(SIG)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Signal Token (CURRENCY:SIG) traded 33% higher against the U.S. dollar during the twenty-four hour period ending at 23:00 PM ET on May 12th. During the last seven days, Signal Token has traded 136.8% higher against the U.S. dollar. Signal Token has a market capitalization of $9.93 million and approximately $156,257.00 worth of Signal Token was traded on exchanges in the last 24 hours. One Signal Token token can currently be bought for $0.0450 or 0.00000466 BTC on popular exchanges including HitBTC, EtherDelta (ForkDelta), IDEX and Bancor Network.

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Wednesday was Signet Jewelers Limited (NYSE: SIG) which traded down about 7% at $52.74. The stocks 52-week range is $46.09 to $86.35. Volume was 8.5 million, well above the daily average of 2.4 million shares.

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Wednesday was Signet Jewelers Limited (NYSE: SIG) which traded down about 20% at $38.14. The stocks 52-week range is $38.11 to $77.94. Volume was 25.5 million compared to the daily average volume of 2.1 million.

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Monday was Signet Jewelers Limited (NYSE: SIG) which rose about 2% to $39.48. The stocks 52-week range is $187.96 to $314.86. Volume was 3.8 million compared to the daily average volume of 2.8 million.

Top Medical Stocks To Watch Right Now: MobileIron, Inc.(MOBL)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on MobileIron (MOBL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Medical Stocks To Watch Right Now: Applied DNA Sciences Inc(APDN)

Advisors’ Opinion:

  • [By Max Byerly]

    These are some of the media headlines that may have effected Accern Sentiment’s rankings:

    Get Applied DNA Sciences alerts:

    Applied DNA Sciences’ (APDN) CEO James Hayward on Q2 2018 Results – Earnings Call Transcript (seekingalpha.com) Edited Transcript of APDN earnings conference call or presentation 3-May-18 8:30pm GMT (finance.yahoo.com) Applied DNA Sciences: Fiscal 2Q Earnings Snapshot (finance.yahoo.com) Applied DNA Sciences (APDN) Stock Rating Upgraded by ValuEngine (americanbankingnews.com) Applied DNA Reports Fiscal Second Quarter 2018 Financial Results (finance.yahoo.com)

    A number of research analysts have issued reports on the stock. Maxim Group set a $5.00 price target on shares of Applied DNA Sciences and gave the stock a “buy” rating in a report on Friday, April 6th. ValuEngine raised shares of Applied DNA Sciences from a “strong sell” rating to a “sell” rating in a report on Friday, February 2nd.

  • [By Shane Hupp]

    Ascent Capital Group (NASDAQ: ASCMA) and Applied DNA Sciences (NASDAQ:APDN) are both small-cap industrial products companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, risk, profitability, earnings and institutional ownership.

Leave a Reply

Your email address will not be published. Required fields are marked *